NO164773C - Analogifremgangsmaate for fremstilling av forbindelser medfarmasoeytisk virkning. - Google Patents

Analogifremgangsmaate for fremstilling av forbindelser medfarmasoeytisk virkning.

Info

Publication number
NO164773C
NO164773C NO830416A NO830416A NO164773C NO 164773 C NO164773 C NO 164773C NO 830416 A NO830416 A NO 830416A NO 830416 A NO830416 A NO 830416A NO 164773 C NO164773 C NO 164773C
Authority
NO
Norway
Prior art keywords
compounds
preparation
pharmaceutical effect
analogue procedure
analogue
Prior art date
Application number
NO830416A
Other languages
English (en)
Norwegian (no)
Other versions
NO830416L (no
NO164773B (no
Inventor
Rudolf K A Giger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO830416L publication Critical patent/NO830416L/no
Publication of NO164773B publication Critical patent/NO164773B/no
Publication of NO164773C publication Critical patent/NO164773C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO830416A 1982-02-12 1983-02-09 Analogifremgangsmaate for fremstilling av forbindelser medfarmasoeytisk virkning. NO164773C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH89382 1982-02-12
CH692482 1982-11-29

Publications (3)

Publication Number Publication Date
NO830416L NO830416L (no) 1983-08-15
NO164773B NO164773B (no) 1990-08-06
NO164773C true NO164773C (no) 1990-11-14

Family

ID=25686031

Family Applications (1)

Application Number Title Priority Date Filing Date
NO830416A NO164773C (no) 1982-02-12 1983-02-09 Analogifremgangsmaate for fremstilling av forbindelser medfarmasoeytisk virkning.

Country Status (31)

Country Link
US (1) US4737499A (fr)
KR (1) KR890000813B1 (fr)
AT (1) AT382874B (fr)
AU (1) AU564596B2 (fr)
CA (1) CA1245641A (fr)
CH (1) CH658249A5 (fr)
CS (1) CS236782B2 (fr)
CY (1) CY1432A (fr)
DD (1) DD208356A5 (fr)
DE (1) DE3303616A1 (fr)
DK (1) DK62283A (fr)
ES (1) ES519687A0 (fr)
FI (1) FI71941C (fr)
FR (1) FR2522663B1 (fr)
GB (1) GB2114980B (fr)
GR (1) GR77417B (fr)
HK (1) HK53088A (fr)
IE (1) IE54501B1 (fr)
IL (1) IL67883A (fr)
IT (1) IT1197571B (fr)
KE (1) KE3811A (fr)
MY (1) MY8600569A (fr)
NL (1) NL8300484A (fr)
NO (1) NO164773C (fr)
NZ (1) NZ203252A (fr)
PH (1) PH21234A (fr)
PL (1) PL140363B1 (fr)
PT (1) PT76222B (fr)
SE (1) SE455097B (fr)
SG (1) SG22588G (fr)
WO (1) WO1983002775A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU571927B2 (en) * 1979-06-12 1988-04-28 Sandoz Ltd. A 2-methyl ergot peptide alkaloid
HU195729B (en) * 1985-02-05 1988-07-28 Sandoz Ag Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides
US7771746B2 (en) * 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
US6831216B2 (en) * 2002-05-21 2004-12-14 Holden's Foundation Seeds Llc Inbred corn line LH247

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH503031A (de) * 1967-04-12 1971-02-15 Sandoz Ag Verfahren zur Herstellung heterocyclischer Verbindungen
CH563393A5 (en) * 1967-08-02 1975-06-30 Sandoz Ag Ergot derivs andrenolytics
CH505102A (de) * 1967-11-01 1971-03-31 Sandoz Ag Verfahren zur Herstellung neuer Mutterkornpeptidalkaloide
FI56386C (fi) * 1973-07-09 1980-01-10 Sandoz Ag Foerfarande foer framstaellning av oktahydro-oxazolo(3,2-a)pyrrolo(2,1-c)pyrazin-derivat
CH602765A5 (fr) * 1974-09-27 1978-07-31 Sandoz Ag
CH601321A5 (fr) * 1975-01-06 1978-07-14 Sandoz Ag
US4138565A (en) * 1975-05-31 1979-02-06 Sandoz Ltd. Stable solutions and processes for their preparation
CH619468A5 (fr) * 1976-01-12 1980-09-30 Sandoz Ag
DE3340025C2 (de) * 1983-11-03 1986-01-09 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 2-Brom-8-ergolinyl-Verbindungen

Also Published As

Publication number Publication date
FR2522663B1 (fr) 1985-06-14
IE830282L (en) 1983-08-12
PL240540A1 (en) 1984-06-18
DE3303616A1 (de) 1983-08-25
IE54501B1 (en) 1989-10-25
DK62283A (da) 1983-08-13
HK53088A (en) 1988-07-22
FI71941B (fi) 1986-11-28
SE8300711L (sv) 1983-08-13
US4737499A (en) 1988-04-12
IT1197571B (it) 1988-12-06
CA1245641A (fr) 1988-11-29
SG22588G (en) 1988-07-15
WO1983002775A1 (fr) 1983-08-18
DK62283D0 (da) 1983-02-11
AU564596B2 (en) 1987-08-20
GB2114980B (en) 1985-10-30
PT76222A (en) 1983-03-01
NL8300484A (nl) 1983-09-01
AT382874B (de) 1987-04-27
FI830399A0 (fi) 1983-02-04
PH21234A (en) 1987-08-21
PT76222B (en) 1986-01-15
FI830399L (fi) 1983-08-13
FI71941C (fi) 1987-03-09
NO830416L (no) 1983-08-15
AU1129283A (en) 1983-08-18
IT8347702A0 (it) 1983-02-11
ES8500280A1 (es) 1984-10-01
KE3811A (en) 1988-08-05
SE8300711D0 (sv) 1983-02-10
DD208356A5 (de) 1984-05-02
SE455097B (sv) 1988-06-20
NO164773B (no) 1990-08-06
IL67883A0 (en) 1983-06-15
PL140363B1 (en) 1987-04-30
ES519687A0 (es) 1984-10-01
CY1432A (en) 1988-09-02
KR890000813B1 (ko) 1989-04-08
CH658249A5 (de) 1986-10-31
GB8303475D0 (en) 1983-03-16
IL67883A (en) 1986-03-31
MY8600569A (en) 1986-12-31
NZ203252A (en) 1986-08-08
CS236782B2 (en) 1985-05-15
GB2114980A (en) 1983-09-01
KR840003642A (ko) 1984-09-15
ATA47583A (de) 1986-09-15
FR2522663A1 (fr) 1983-09-09
GR77417B (fr) 1984-09-13

Similar Documents

Publication Publication Date Title
NO833705L (no) Fremgangsmaate for fremstilling av fenyl-piperidin-propanol-forbindelser.
NO156785B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO163668C (no) Fremgangsmaate for fremstilling av immunogent kompleks.
NO167810C (no) Analogifremgangsmaate til fremstilling av insulinderivater.
NO832701L (no) Fremgangsmaate til fremstilling av metylen-difosfonsyre-derivater.
NO161002C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider.
NO165027C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive propenyl-cefalosporinforbindelser.
NO157861C (no) Analogifremgangsmaate til fremstilling av aminopyridaziner.
NO154492C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme forbindelser.
NO822704L (no) Fremgangsmaate for fremstilling av insulinderivater.
NO162817C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4-aryl-4-piperidin-carbinoler.
NO155693C (no) Fremgangsmaate for fremstilling av eburnamoninderivater.
NO157735C (no) Fremgangsmaate for fremstilling av alfa-arylalkansyrer.
NO833531L (no) Fremgangsmaate for fremstilling av 7-substituerte-3-vinyl-3-cefem-forbindelser
NO159090C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.
NO158800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater.
NO162018C (no) Fremgangsmaate for fremstilling av 4-metyl-5-alkyltiometylimidazoler.
NO160203C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme fenotiazin-forbindelser.
NO164773C (no) Analogifremgangsmaate for fremstilling av forbindelser medfarmasoeytisk virkning.
FI792303A (fi) Farmaceutisk komposition foer rektal administration av kefalosporin
NO155842C (no) Analogifremgangsmaate ved fremstilling av terapeutiske aktive 2-beta-d-ribofuranosylselenazol-4-carboxamider.
NO831874L (no) Fremgangsmaate for fremstilling av trifenylbuten-derivater
NO160136C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av benzoylfenylpiperidin.
NO163327C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydropyridiner.